“…While most P300-based BCIs have been studied mainly in healthy volunteers (HVs), their usage has been explored in small numbers of people with ALS or other severe neuromuscular disabilities (Escolano et al, 2010, Hoffmann et al, 2008, Ikegami et al, 2014, Kaufmann et al, 2013a, Kubler and Birbaumer, 2008, Kubler et al, 2009, Manyakov et al, 2011, McFarland et al, 2011, Nijboer et al, 2008, Pires et al, 2011, Pires et al, 2012, Sellers and Donchin, 2006, Sellers et al, 2010, Silvoni et al, 2009, Spuler et al, 2012, Townsend et al, 2010). Visual problems can occur in people with advanced ALS (e.g.…”